TEX13B
gene geneOn this page
Also known as TSGA5TGC3B
Summary
TEX13B (testis expressed 13B, HGNC:11736) is a protein-coding gene on chromosome Xq22.3, encoding Testis-expressed protein 13B (Q9BXU2).
This gene is similar to a mouse gene that is expressed in the testis.
Source: NCBI Gene 56156 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_031273
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11736 |
| Approved symbol | TEX13B |
| Name | testis expressed 13B |
| Location | Xq22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TSGA5, TGC3B |
| Ensembl gene | ENSG00000170925 |
| Ensembl biotype | protein_coding |
| OMIM | 300313 |
| Entrez | 56156 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000302917
RefSeq mRNA: 1 — MANE Select: NM_031273
NM_031273
CCDS: CCDS14534
Canonical transcript exons
ENST00000302917 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001153464 | 107982310 | 107982370 |
| ENSE00001164893 | 107980864 | 107981559 |
| ENSE00001164901 | 107981669 | 107982159 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 87.87.
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.87 | gold quality |
| myocardium | UBERON:0002349 | 67.70 | gold quality |
| sperm | CL:0000019 | 66.80 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.66 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 63.18 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 63.12 | gold quality |
| superficial temporal artery | UBERON:0001614 | 61.85 | gold quality |
| cartilage tissue | UBERON:0002418 | 59.80 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 58.86 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 58.78 | gold quality |
| tibia | UBERON:0000979 | 57.93 | gold quality |
| secondary oocyte | CL:0000655 | 57.64 | gold quality |
| seminal vesicle | UBERON:0000998 | 57.43 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 57.42 | gold quality |
| vastus lateralis | UBERON:0001379 | 57.36 | gold quality |
| quadriceps femoris | UBERON:0001377 | 57.31 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 57.29 | gold quality |
| mammalian vulva | UBERON:0000997 | 57.06 | gold quality |
| saphenous vein | UBERON:0007318 | 56.81 | gold quality |
| medulla oblongata | UBERON:0001896 | 56.71 | gold quality |
| pericardium | UBERON:0002407 | 56.71 | gold quality |
| ventral tegmental area | UBERON:0002691 | 56.58 | gold quality |
| nipple | UBERON:0002030 | 56.53 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 56.52 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 56.51 | gold quality |
| urethra | UBERON:0000057 | 56.49 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 56.42 | gold quality |
| thymus | UBERON:0002370 | 56.29 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 56.29 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 56.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting TEX13B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-942-5P | 99.41 | 68.40 | 1977 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-6728-3P | 98.63 | 67.63 | 1534 |
| HSA-MIR-3188 | 98.58 | 65.60 | 878 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-93-3P | 98.15 | 66.65 | 1309 |
| HSA-MIR-4421 | 97.99 | 64.89 | 701 |
| HSA-MIR-6847-5P | 97.93 | 66.74 | 1808 |
| HSA-MIR-5699-3P | 97.81 | 65.00 | 861 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex13b | ENSMUSG00000042386 |
| mus_musculus | Tex13a | ENSMUSG00000071686 |
| rattus_norvegicus | Tex13a | ENSRNOG00000026712 |
| rattus_norvegicus | Tex13b | ENSRNOG00000058904 |
| drosophila_melanogaster | CG14718 | FBGN0037939 |
Paralogs (3): TEX13A (ENSG00000268629), TEX13D (ENSG00000282419), TEX13C (ENSG00000282815)
Protein
Protein identifiers
Testis-expressed protein 13B — Q9BXU2 (reviewed: Q9BXU2)
All UniProt accessions (1): Q9BXU2
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Testis specific.
Similarity. Belongs to the TEX13 family.
RefSeq proteins (1): NP_112563* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028193 | TEX13A-D_N | Domain |
| IPR054602 | ||
| IPR055047 |
Pfam: PF15186, PF22835, PF22836
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BXU2-F1 | 69.29 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 31 (showing top):
SHEN_SMARCA2_TARGETS_DN, GOMF_MRNA_BINDING, MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED, MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, chrXq22, FOSTER_KDM1A_TARGETS_UP, PTEN_DN.V2_DN, DCA_UP.V1_UP, IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP, MIR6828_5P, GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN, GSE27786_LIN_NEG_VS_CD8_TCELL_UP, GSE27786_LIN_NEG_VS_NEUTROPHIL_UP
GO Biological Process (0):
GO Molecular Function (2): mRNA binding (GO:0003729), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
728 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX13B | ZNF711 | Q9Y462 | 493 |
| TEX13B | H3BQ15 | H3BQ15 | 471 |
| TEX13B | DIAPH2 | O60879 | 470 |
| TEX13B | AMDHD2 | Q9Y303 | 470 |
| TEX13B | ZNF142 | P52746 | 456 |
| TEX13B | ZMYM6 | O95789 | 429 |
| TEX13B | TRIM48 | Q8IWZ4 | 419 |
| TEX13B | FTHL17 | Q9BXU8 | 399 |
| TEX13B | ZYG11A | Q6WRX3 | 397 |
| TEX13B | VSIG1 | Q86XK7 | 394 |
| TEX13B | NBEAL1 | Q6ZS30 | 379 |
| TEX13B | ZFX | P17010 | 358 |
| TEX13B | POLR3C | Q9BUI4 | 352 |
| TEX13B | LRRC3 | Q9BY71 | 326 |
| TEX13B | ZC3H14 | Q6PJT7 | 322 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VSNL1 | TEX13B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX13B | HPCAL4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX13B | ARID1A | psi-mi:“MI:0914”(association) | 0.350 |
| TEX13A | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| TEX13B | VSNL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TEX13B | HPCAL4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| VSNL1 | TEX13B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): TEX13B (Two-hybrid), TEX13B (Two-hybrid), THTPA (Affinity Capture-MS), SMARCD3 (Affinity Capture-MS), SMARCB1 (Affinity Capture-MS), SMARCC1 (Affinity Capture-MS), ARID2 (Affinity Capture-MS), ARID1B (Affinity Capture-MS), SMARCD2 (Affinity Capture-MS), ARID1A (Affinity Capture-MS), DPF3 (Affinity Capture-MS), CRLF2 (Affinity Capture-MS), SMARCC2 (Affinity Capture-MS), SMARCD1 (Affinity Capture-MS), DPF2 (Affinity Capture-MS)
ESM2 similar proteins: A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NEF3, A6NEM1, A6NI86, A6NJZ7, A6NMD2, A6NN73, A6NNM3, A7E2F4, A8MQT2, D6RF30, F8WBI6, H0YKK7, H3BPF8, H3BQL2, H3BSY2, H3BV12, I6L899, M3WHG5, P0C7N4, P0CG33, P0CJ92, P0DX52, P0DX53, P54257, Q0D2H9, Q2M243, Q3T1I3, Q3TCJ8, Q3V0F0, Q497K7, Q5D525, Q7Z572, Q7Z6P3, Q86XG9, Q8C0G2, Q8C0X0
Diamond homologs: A0A0J9YWL9, A0A0J9YY54, A2AFS9, D3YU32, Q9BXU2, Q9BXU3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
466 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:107981667:A:AC | donor_gain | 0.9900 |
| X:107981668:C:CC | donor_gain | 0.9900 |
| X:107981668:CGG:C | donor_gain | 0.9900 |
| X:107981683:T:TA | donor_gain | 0.9900 |
| X:107981667:ACGG:A | donor_gain | 0.9700 |
| X:107981668:CGGC:C | donor_gain | 0.9700 |
| X:107982159:CCTG:C | acceptor_gain | 0.9700 |
| X:107981684:C:A | donor_gain | 0.9400 |
| X:107981937:TTG:T | donor_gain | 0.9300 |
| X:107982158:CC:C | acceptor_gain | 0.9200 |
| X:107981668:CG:C | donor_gain | 0.9100 |
| X:107982161:T:A | acceptor_loss | 0.9100 |
| X:107981661:GATCT:G | donor_loss | 0.9000 |
| X:107981662:ATCTT:A | donor_loss | 0.9000 |
| X:107981663:TCTTA:T | donor_loss | 0.9000 |
| X:107981664:CT:C | donor_loss | 0.9000 |
| X:107981665:TT:T | donor_loss | 0.9000 |
| X:107981666:TACGG:T | donor_loss | 0.9000 |
| X:107981667:A:C | donor_loss | 0.9000 |
| X:107981668:C:A | donor_loss | 0.9000 |
| X:107981668:CGGCA:C | donor_gain | 0.9000 |
| X:107982158:CCCTG:C | acceptor_gain | 0.9000 |
| X:107982160:C:CC | acceptor_gain | 0.9000 |
| X:107981559:CCTGG:C | acceptor_loss | 0.8900 |
| X:107981560:CTGGA:C | acceptor_loss | 0.8900 |
| X:107981660:GGATC:G | donor_loss | 0.8900 |
| X:107981561:T:A | acceptor_loss | 0.8800 |
| X:107981560:C:CC | acceptor_gain | 0.8700 |
| X:107982141:C:A | acceptor_gain | 0.8700 |
| X:107982304:CCTCA:C | donor_loss | 0.8700 |
AlphaMissense
2025 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:107982026:G:C | F34L | 0.977 |
| X:107982026:G:T | F34L | 0.977 |
| X:107982028:A:G | F34L | 0.977 |
| X:107982092:G:C | F12L | 0.967 |
| X:107982092:G:T | F12L | 0.967 |
| X:107982094:A:G | F12L | 0.967 |
| X:107982068:G:C | F20L | 0.948 |
| X:107982068:G:T | F20L | 0.948 |
| X:107982070:A:G | F20L | 0.948 |
| X:107981999:C:A | W43C | 0.937 |
| X:107981999:C:G | W43C | 0.937 |
| X:107982001:A:G | W43R | 0.933 |
| X:107982001:A:T | W43R | 0.933 |
| X:107981923:A:G | W69R | 0.920 |
| X:107981923:A:T | W69R | 0.920 |
| X:107981921:C:A | W69C | 0.909 |
| X:107981921:C:G | W69C | 0.909 |
| X:107982093:A:G | F12S | 0.908 |
| X:107981915:G:C | S71R | 0.902 |
| X:107981915:G:T | S71R | 0.902 |
| X:107981917:T:G | S71R | 0.902 |
| X:107982027:A:G | F34S | 0.901 |
| X:107981987:T:A | E47D | 0.900 |
| X:107981987:T:G | E47D | 0.900 |
| X:107981894:A:C | F78L | 0.878 |
| X:107981894:A:T | F78L | 0.878 |
| X:107981896:A:G | F78L | 0.878 |
| X:107982037:C:G | G31R | 0.872 |
| X:107982093:A:C | F12C | 0.860 |
| X:107982014:A:C | N38K | 0.848 |
dbSNP variants (sampled 300 via entrez): RS1007306452 (X:107984245 T>A), RS1007345717 (X:107980815 A>C,G), RS1008329599 (X:107982813 G>A), RS1008404561 (X:107983103 G>A), RS1008986803 (X:107981996 C>T), RS1010011952 (X:107982121 A>G), RS1010372156 (X:107983493 T>A), RS1013691830 (X:107983261 C>G,T), RS1017597061 (X:107981817 G>A), RS1017671165 (X:107980829 T>C,G), RS1017901443 (X:107983805 A>AT), RS1018677002 (X:107982815 C>T), RS1019981423 (X:107983512 G>C), RS1021023497 (X:107984321 G>A,C), RS1022277002 (X:107982132 G>A,C)
Disease associations
OMIM: gene MIM:300313 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, affects methylation | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arbutin | decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.